ZURICH, Switzerland, September 1, 2011 /PRNewswire/ –
Study Assessing the Safety and Efficacy of KUR-211 Expected to Report in mid 2012
Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for…
Popularity: 2% [?]

